# TechDoctor

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/techdoctor

- Industry: Healthcare IT
- Headquarters: Tokyo, Japan
- Website: www.technology-doctor.com
- Total disclosed funding: $4.6M
- Latest round: Series B (May 7, 2025)
- Investors on record: 11

## About

Based in Japan, TechDoctor Inc. specializes in developing digital biomarkers and providing remote medical support to enhance healthcare services through innovative technology.TechDoctor Inc. is focused on creating digital health solutions and was founded in 2019 in Tokyo, Japan. The company has completed 4 deals since its inception. The CEO and co-founder, Abu Hanif, has previously been involved in other ventures, contributing to the company's strategic direction. In its latest funding round, the Series A, TechDoctor successfully raised JPY 500.000 mn, achieving a total amount raised of JPY 500.000 mn and a current company valuation of JPY 2,289.815 mn.TechDoctor specializes in the development of digital biomarkers and data-driven remote medical support. Their core product, SelfBase, is a digital biomarker development platform designed to leverage everyday data collected from various devices to enhance healthcare services. The Health Portal aims to utilize daily health data to create innovative healthcare solutions. TechDoctor serves healthcare providers and researchers, primarily focusing on markets in Japan while exploring expansion opportunities in other regions.TechDoctor's revenue model encompasses a mix of subscription services and partnerships with healthcare organizations. Their flagship product, SelfBase, is offered through a subscription pricing structure that enables clients, such as hospitals and research institutions, to access ongoing support and updates. The Health Portal follows a similar model, providing tools to analyze and utilize digital data effectively. Transactions typically occur directly between TechDoctor and its clients, which may include B2B arrangements with healthcare providers and research institutions.In May 2025, TechDoctor Inc. raised JPY 1.2 billion in Series B funding to enhance its research and development of artificial intelligence solutions for healthcare. The company aims to launch new products while expanding into international markets, with a focus on innovation in digital health solutions. The funding will enable TechDoctor to advance its current projects and explore new opportunities to improve healthcare delivery.

## Funding rounds

- Series B, May 7, 2025 — Daiwa Corporate Investment, Nippon Venture Capital, JAFCO Group, Mitsui Sumitomo Insurance Venture Capital, MIRAIDOOR, Resona Capital, YMFG Capital, Lion Corporation, Ono Digital health Investment, GK.
- Series A, Jun 29, 2022, $3.7M — Nippon Venture Capital, JAFCO Group, Mitsui Sumitomo Insurance Venture Capital, Mizuho Capital, Genesia Ventures
- Seed, May 11, 2021, $0.9M — Genesia Ventures

## Investors

- Genesia Ventures (https://capitalatlas.ai/funds/genesia-ventures) — Seed, Series A
- Nippon Venture Capital (https://capitalatlas.ai/funds/nippon-venture-capital) — Series A, Series B
- JAFCO Group (https://capitalatlas.ai/funds/jafco-group) — Series A, Series B
- Mitsui Sumitomo Insurance Venture Capital (https://capitalatlas.ai/funds/mitsui-sumitomo-insurance-venture-capital) — Series A, Series B
- Mizuho Capital (https://capitalatlas.ai/funds/mizuho-capital) — Series A
- Daiwa Corporate Investment (https://capitalatlas.ai/funds/daiwa-corporate-investment) — Series B
- MIRAIDOOR (https://capitalatlas.ai/funds/miraidoor) — Series B
- Resona Capital (https://capitalatlas.ai/funds/resona-capital) — Series B
- YMFG Capital (https://capitalatlas.ai/funds/ymfg-capital) — Series B
- Lion Corporation — Series B
- Ono Digital health Investment, GK. — Series B